ADAR1 Capital Management »

Traws Pharma shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Traws Pharma (TRAW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Traws Pharma

Tip: Access up to 7 years of quarterly data

All positions including Traws Pharma held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Traws Pharma by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $175k 154k 1.13

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Traws Pharma

Ikarian Capital
OrbiMed Advisors
Adage Capital Partners GP
Boothbay Fund Management
ADAR1 Capital Management
Vanguard Group
Geode Capital Management
Seven Fleet Capital Management
XTX Topco
State Street Corporation
Two Sigma Investments
Susquehanna International
BlackRock
UBS Group
SBI Securities

View all funds holding Traws Pharma